BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Gritstone Bio (formerly -- Gritstone Oncology)

Gritstone Bio (formerly -- Gritstone Oncology) logo

Founded
2015
Patents
16
Clinical Trials
3
Publications
9

Technologies

AI Companies (Drug Discovery)

Gritstone Oncology is a cancer immunotherapy company developing next-generation personalized cancer therapeutics. Gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors, and very deep financial backing to tackle fundamental challenges at the intersection of cancer biology, immunology, and immunotherapy design. The company’s initial goal is to identify and deploy therapeutic neo-antigens from individual patients’ tumors to develop novel treatments for lung cancer.

Become a Member to view additional information about this company